| ISIN | CH0356496742 |
|---|---|
| Valor Number | 35649674 |
| Bloomberg Global ID | UBSEEPW SW |
| Fund Name | UBS (CH) Investment Fund - Equities Europe Passive A-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
| Asset Class | Equities |
| EFC Category | Equity Europe |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The fund invests in stocks of major companies from established markets that are included in the MSCI Europe ex Switzerland Index.|The fund holds almost all stocks in the MSCI Europe ex Switzerland Index. Individual stocks are held in proportion to the free-float market capitalisation of the index.|Diversification is achieved via a mix of sectors and countries and thus offers the investor an optimised risk/return profile.|The investment objective is to generate a performance in line with that of the benchmark, keeping the tracking error below the maximum of 0.5% over a rolling period of 3 years.|The funds described herein are indexed to an MSCI index. |
| Peculiarities |
| Current Price * | 159.13 CHF | 12.12.2025 |
|---|---|---|
| Previous Price * | 159.88 CHF | 11.12.2025 |
| 52 Week High * | 160.06 CHF | 08.12.2025 |
| 52 Week Low * | 125.15 CHF | 09.04.2025 |
| NAV * | 159.13 CHF | 12.12.2025 |
| Issue Price * | 159.13 CHF | 12.12.2025 |
| Redemption Price * | 159.13 CHF | 12.12.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 598,652,294 | |
| Unit/Share Assets *** | 32,086,883 | |
| Trading Information SIX | ||
| YTD Performance | +17.01% |
31.12.2024 - 12.12.2025
31.12.2024 12.12.2025 |
|---|---|---|
| 1 month | -0.08% |
12.11.2025 - 12.12.2025
12.11.2025 12.12.2025 |
| 3 months | +4.50% |
12.09.2025 - 12.12.2025
12.09.2025 12.12.2025 |
| 6 months | +5.09% |
12.06.2025 - 12.12.2025
12.06.2025 12.12.2025 |
| 1 year | +15.22% |
12.12.2024 - 12.12.2025
12.12.2024 12.12.2025 |
| 2 years | +29.88% |
12.12.2023 - 12.12.2025
12.12.2023 12.12.2025 |
| 3 years | +39.71% |
12.12.2022 - 12.12.2025
12.12.2022 12.12.2025 |
| 5 years | +51.84% |
14.12.2020 - 12.12.2025
14.12.2020 12.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS (Lux) IF Eqs Eur exUK exSwt PsvUXacc | 73.77% | |
|---|---|---|
| UBS (CH) IF Eqs UK IX NSL UX-acc | 26.16% | |
| NMC Health PLC | 0.00% | |
| Last data update | 30.11.2025 | |
| TER | 0.23% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.30% |
| Ongoing Charges *** | 0.11% |
|
SRRI ***
|
|
| SRRI date *** | 30.11.2025 |